13F

Stock

Avalo Therapeutics, Inc.

AVTX · held by 98 managers

Reported value

$436.6M

Holders

Holders’ est. mark

Need a prior quarter

Largest holder

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.